- A personalized vaccine for melanoma cut the risk of cancer returning after five years NBC News
- A cancer vaccine made just for you. mRNA is back and it’s fighting melanoma NPR
- Cancer vaccine sustains 49% melanoma reduction after 5 years Medical Xpress
- Moderna and Merck Present 5-Year Data for Intismeran Autogene in Combination With KEYTRUDA (pembrolizumab) in Patients With High-Risk Stage III/IV Melanoma Following Complete Resection at the 2026 ASCO Annual Meeting Times Argus
- A personalised cancer vaccine improves the effectiveness of melanoma treatment, according to a phase 2 trial Science Media Centre España
Add Comment